Publications (1)0 Total impact
ABSTRACT: As the incidence of cancer continues to escalate, the demand for alternative anticancer therapeutics increases. The use of
viruses in cancer treatment is well documented (1); however, as knowledge in the fields of virology, cell biology, and oncology expands, refined techniques and novel viral-based
therapeutics emerge. The oncolytic potential of a wide spectrum of viruses has been explored, such as adenovirus (2,3), herpes simplex virus (HSV) (4,5), vesicular stomatitis virus (6), vaccinia virus (7), poliovirus (8), and mammalian reovirus (9).
11/2007: pages 249-260;
The University of Calgary
Department of Microbiology, Immunology and Infectious Diseases